Experts expose 75% lethal Lepto virus outbreak in China warning of fear of next pandemic

Wuhan pneumonia (novel coronavirus disease, COVID-19) Epidemic has not slowed down, the non-profit organization recently released a report saying that the world is still not prepared for a possible future outbreak, and pointed out that the lethal rate of up to 75% of the Lipah virus (Nipah Virus) fears to become the next global pandemic disease.

Chuang Renxiang: will monitor the international epidemic at all times

The central epidemic command center spokesman Zhuang Renxiang said in the face of media inquiries, which virus will be a pandemic is difficult to predict, but will monitor the international epidemic at any Time. The natural host of the virus is the bat, mainly found in several countries, in 1999 in Malaysia and Singapore, in 2010 in Bangladesh found, like this Covid-19, although it happened in other countries, but we also monitor from time to time, will do a risk assessment, once the relevant situation will do contingency preparations.

The Access to Medicine Foundation, a non-profit organization headquartered in the Netherlands, recently released its annual research report on the 16 infectious diseases announced by the World health Organization (WHO) and found that pharmaceutical companies are prepared for 10 diseases, including the Lepto virus. The report points out that the next pandemic may break out when the pharmaceutical companies are not ready for it.

Jayasree K Iyer, executive director of the Drug Access Foundation, said that Lipavirus is another emerging infectious disease of concern that could break out at any time. The outbreak in China, which has a 75 percent fatality rate, has the potential to become the next pandemic.

Lepto virus is carried by specific species of bats and pigs, and can be transmitted directly from person to person, as well as through contaminated Food, and there have been several outbreaks in East and South Asia. Infection with Lepto virus can lead to severe respiratory problems and encephalitis, with a mortality rate of about 40% to 75%, and there is still no vaccine to treat it.

The report notes that despite years of warnings that a new coronavirus could emerge and cause a global public health crisis, pharmaceutical manufacturers and society at large were apparently ill-prepared for a pneumonia pandemic in Wuhan. A total of 63 vaccines and drugs have now been approved or are in development in the wake of the outbreak.

Without the continued commitment of large pharmaceutical companies to pandemic response, the report says, the world will remain vulnerable to future pandemics, with low-income countries particularly vulnerable. Lepto virus is currently one of the diseases that has received the most attention from experts, with outbreaks in countries such as India and Bangladesh, in addition to China.